Search for other papers by Luciana Puleo in
Google Scholar
PubMed
Search for other papers by Laura Agate in
Google Scholar
PubMed
Search for other papers by Irene Bargellini in
Google Scholar
PubMed
Search for other papers by Giuseppe Boni in
Google Scholar
PubMed
Search for other papers by Paolo Piaggi in
Google Scholar
PubMed
Search for other papers by Claudio Traino in
Google Scholar
PubMed
Search for other papers by Tommaso Depalo in
Google Scholar
PubMed
Search for other papers by Giulia Lorenzoni in
Google Scholar
PubMed
Search for other papers by Francesca Bianchi in
Google Scholar
PubMed
Search for other papers by Duccio Volterrani in
Google Scholar
PubMed
Search for other papers by Sandra Brogioni in
Google Scholar
PubMed
Search for other papers by Valeria Bottici in
Google Scholar
PubMed
Search for other papers by Maurizia Rossana Brunetto in
Google Scholar
PubMed
Search for other papers by Barbara Coco in
Google Scholar
PubMed
Search for other papers by Eleonora Molinaro in
Google Scholar
PubMed
Search for other papers by Rossella Elisei in
Google Scholar
PubMed
labeled with the β-emitting radioisotope yttrium-90 has been used for the treatment of inoperable liver malignancies ( 8 , 9 ). In the last decade, this technique has been proposed mostly for the treatment of primary liver carcinomas ( 10 , 11 , 12
Search for other papers by Carles Zafon in
Google Scholar
PubMed
Department of Medicine, University of Alcalá de Henares, Madrid
Search for other papers by Juan J. Díez in
Google Scholar
PubMed
IdiSNA (Instituto de investigación en la salud de Navarra), Pamplona, Spain
Search for other papers by Juan C. Galofré in
Google Scholar
PubMed
Search for other papers by David S. Cooper in
Google Scholar
PubMed
receptor radionuclide therapy of treatment-refractory metastatic thyroid cancer using (90)yttrium and (177)lutetium labeled somatostatin analogs: toxicity, response and survival analysis. Am J Nucl Med Mol Imaging 2013;4:39-52. 62 Salavati A
Search for other papers by M. Schlumberger in
Google Scholar
PubMed
Search for other papers by L. Bastholt in
Google Scholar
PubMed
Search for other papers by H. Dralle in
Google Scholar
PubMed
Search for other papers by B. Jarzab in
Google Scholar
PubMed
Search for other papers by F. Pacini in
Google Scholar
PubMed
Search for other papers by J.W.A. Smit in
Google Scholar
PubMed
experience with radiolabeled molecules, only few responses have been reported with [ 90 yttrium[0]DOTA]-TOC in MTC patients with rising Ct levels and tumor uptake on 111 In-Octreoscan [ 53 ]. With pretargeted radioimmunotherapy with bispecific monoclonal